Bruker Daltonik and VWR Sign Mass Spec Co-Marketing Pact | GenomeWeb

NEW YORK, May 11 (GenomeWeb News) - Bruker Daltonik, a subsidiary of Bruker BioSciences, today said that it has signed an agreement with VWR International's Scientific Instruments business unit to jointly market certain VWR HPLC and Bruker Daltonik bench-top mass spectrometers in Europe.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.